Ondansetron Hikma

What is Ondansetron?

Ondondansetron, the active ingredient in Ondansetron Hikma, is a 5-HT3 receptor antagonist presented as a strength/form for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiotherapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondansetron Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Ondansetron used for?

Ondansetron Hikma is a selective 5‑HT3 receptor antagonist that reduces nausea and vomiting across several clinical pathways.

- Chemotherapy‑induced nausea and vomiting: Helps ... - Post‑operative ... - Radiotherapy ... ... - ... - ... - ...

What are the side effects of Ondansetron?

… … .... … ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →